COX-2: A Pivotal Enzyme in Mucosal Protection and Resolution of Inflammation

The discovery of a second form of cyclooxygenase, COX-2, led to a burst of research aimed at the development of nonsteroidal anti-inflammatory drugs that would not damage the gastrointestinal tract. In the years since, this promise has only been partially fulfilled. Selective COX-2 inhibitors cause...

Descripción completa

Detalles Bibliográficos
Autor principal: Wallace, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2006
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917273/
https://www.ncbi.nlm.nih.gov/pubmed/16752007
http://dx.doi.org/10.1100/tsw.2006.122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917273/
https://www.ncbi.nlm.nih.gov/pubmed/16752007
http://dx.doi.org/10.1100/tsw.2006.122

Ejemplares similares